COMPASS Pathways

CMPS | NASDAQ

Price Alert Chart Builder DCF Calculator

$14.88

-$0.13 (-0.87%)

Sep 22, 2026, 11:11 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-0.87%

(1D)

Rating

Updated: Aug 29, 2026

19.7

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $2.01B

1D Range

14.82 15.35

52W Range

4.88 15.87

Valuation (TTM)

PE -2.69

PB 23.96

EV/EBITDA -4.20

Valuation (NTM)

Forward PE N/A

Forward PEG 0.10

Price Target $18.63

Cash Flow

FCF Yield -10.3%

SBC Adj. FCF Yield -11.1%

SBC Impact -7.6%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -50.3% | -23.6%

FCF 3Y | 5Y -35.7% | -22.5%

Returns

ROA -78.1%

ROE -398.2%

ROIC -129.7%

Financial Health

Net Cash

$382.57M

Current Ratio 1.30

Interest Coverage -35.08

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on develo...

Sector Healthcare

Industry Biotechnology

Employees 156

IPO Date Sep 17, 2020

Website compasspathways.com

Fiscal Year January - December

Full Company Profile

Latest News

4 days ago · seekingalpha.com

COMPASS Pathways plc (CMPS) Presents at Deutsche Bank 2026 Healthcare Summit Transcript

6 days ago · seekingalpha.com

COMPASS Pathways plc (CMPS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

2 months ago · seekingalpha.com

COMPASS Pathways plc (CMPS) Q2 2026 Earnings Call Transcript

2 months ago · defenseworld.net

Compass Pathways (CMPS) to Post Quarterly Earnings on Thursday

Compass Pathways (NASDAQ: CMPS - Get Free Report) is expected to release its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect the company to announce earnings of ($0.3857) per share for the quarter. Investors are encouraged to explore the company's upcoming Q2 2026 earning report for the latest details on the

3 months ago · seekingalpha.com

COMPASS Pathways plc (CMPS) Discusses Six-Month Data from Second Phase 3 Trial Confirming Rapid and Durable Profile in Depression Transcript

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$18

Upside

+20.97%

Buy (10)

Hold (0)

Sell (0)

Analyst Details ➞